In 2025, medical device manufacturers are grappling with heightened regulatory uncertainty, leading to slower reviews and communication difficulties with the FDA. This situation drives them to reassess operations for compliance and risk management, with a strong emphasis on maintaining product quality, which is vital for patient safety.
Why it Pays to Prioritize Quality Amid Regulatory Uncertainty
Related Posts
Evaluating Large Language Models (LLMs): Key Factors to Consider
An Overview of Large Language Models (LLMs) Why is LLM Evaluation Necessary? Factors to Consider When Evaluating LLMs…
Trends in Machine Vision: AI is Here to Stay
Artificial intelligence (AI) is currently the leading trend in machine vision. Every major machine vision software package incorporates…
Teledyne FLIR IIS USB3 Machine Vision Camera Series
The Dragonfly S series combines Teledyne’s expertise in USB and experience delivering embedded camera solutions for industries ranging…